-transparent.png){kind=logo}
Plasma prostaglandin F (PGF) was measured by a radioimmunoassay method in 24 subjects with tumours of the female genital tract. Levels in the tumour group ranged from 25 pg/ml to 134 pg/ml and were almost all greater than the values observed in a control group of 41 healthy women who had a mean (+/-SD) level of 21 (+/-3.4)pg/ml. There was a relationship between plasma PGF levels and the stage of the disease. Patients with resectable tumours showed a fall in PGF levels postoperatively and those with disseminated malignancy demonstrated increasing levels as the disease progressed. Plasma PGF may provide a clinical prognostic marker in the management of patients with malignant tumours.
R R Sanders, and
W H Lee, and
L Koh, and
A Brennecke, and
W R Jones
March 2004,
East African medical journal,
R R Sanders, and
W H Lee, and
L Koh, and
A Brennecke, and
W R Jones
January 1976,
Bulletin of the World Health Organization,
R R Sanders, and
W H Lee, and
L Koh, and
A Brennecke, and
W R Jones
February 2010,
Histopathology,
R R Sanders, and
W H Lee, and
L Koh, and
A Brennecke, and
W R Jones
April 1958,
The Journal of obstetrics and gynaecology of the British Empire,
R R Sanders, and
W H Lee, and
L Koh, and
A Brennecke, and
W R Jones
January 2020,
Histopathology,
R R Sanders, and
W H Lee, and
L Koh, and
A Brennecke, and
W R Jones
September 2017,
Current oncology reports,
R R Sanders, and
W H Lee, and
L Koh, and
A Brennecke, and
W R Jones
September 2012,
Ghana medical journal,
R R Sanders, and
W H Lee, and
L Koh, and
A Brennecke, and
W R Jones
December 2010,
Ceska gynekologie,
R R Sanders, and
W H Lee, and
L Koh, and
A Brennecke, and
W R Jones
June 2009,
Taiwanese journal of obstetrics & gynecology,
R R Sanders, and
W H Lee, and
L Koh, and
A Brennecke, and
W R Jones
May 1993,
Zhonghua fu chan ke za zhi,
